Vitamin A Supplementation Effects on Gene Expression of Cytokines Secreted by TCD4+ Lymphocytes in Atherosclerotic Patients  by Keshavarz, Seyed Ali et al.
O
R
A
L
SGeneral
OP-119
Vitamin A Supplementation Effects on Gene Expression of Cytokines Secreted
by TCD4+ Lymphocytes in Atherosclerotic Patients
Seyed Ali Keshavarz, Azadeh Mottaghi, Ali Akbar Saboor Yaraghi, Khadijeh Mirzaei
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Aim: Atherosclerosis is an inﬂammatory arterial wall disease and T lymphocytes have
important role in the pathogenesis and progression of this disease. The aim of this
study is determination of vitamin A supplementation effects on gene expression of
cytokines secreted by TCD4+ lymphocytes in atherosclerotic patients.
Methods-Materials: Thirty one atherosclerotic patients and 12 healthy controls
participated in this study. Patients were randomly divided into vitamin A receiving
group (n¼16) and placebo receiving group (n¼15), also healthy controls were
receiving vitamin A. vitamin A supplement was given as retinyl palmitate and 25000
IU per day. Fasting blood sample of participants were taken before and after 4 months
and plasma was separated and stored at -80 0C for biochemical laboratory tests.
Peripheral blood mononuclear cells (PBMC) were separated and cultured in the
appropriate number along with PHA and ox-LDL for proliferation assay and deter-
mination of gene expression pattern. As well as RNA was extracted and cDNA was
synthesized from part of the cells at the same time and was stored for Real-Time PCR
analysis. After 72 hour incubation cells supernatant were collected and stored at-800C;
cells deposited were collected for PNA extraction and cDNA synthesis. After the
intervention period the gene expression pattern of relevant cytokines of CD4+ T cells
including Th1, Th2, Th17 and Treg were determined by Real-Time PCR.
Results: There was signiﬁcant difference in fasting blood sugar, total cholesterol and
LDL cholesterol between three groups of study, before and after intervention. Vitamin
A increased proliferation of cells that stimulated with ox-LDL in all groups. Results of
this study show that IFN-y and T- bet gene expression in fresh cells in vitamin A-
treated patients was decreased. The IL-4 gene expression was increased 12.7 fold in
vitamin A-treated patients. IL-17 gene expression in fresh cells of vitamin A-treated
patients was diminished. Foxp3 gene expression in fresh cells was increased after
intervention in all groups.
Conclusion: vitamin A supplementation had no signiﬁcant effect on anthropometric
factors and effect of this intervention on biochemical factors limited to increase in total
cholesterol and HDL cholesterol in both groups of patients and controls but the amounts
were in normal value ranges. Vitamin A supplementation could reduce gene expression
of IFN-y T-bet in all patients. Increase in gene expression of Th2 cells was seen in all
group expect GATA3 gene. According to the results of how the effect of vitamin A on
gene expression in atherosclerotic patients, perhaps we thought the positive role of
vitamin A supplementation in these patients. Results of this study could pave the way for
a more detailed review on effect of vitamin A in patients with immune related diseases.
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Background: Coronary artery ectasia (CAE) is deﬁned as local or generalized aneu-
rysmal dilatation of the coronary arteries. Although the etiology of CAE has not been
identiﬁed completely, the most frequent cause is coronary atherosclerosis. It is known
that an expansive remodelling occurs in atherosclerotic coronary arteries due to plague
rupture and increased plague burden particularly in early stages. b-ﬁbrinogen -455 G/A
genotypes have been described to be associated with coronary artery disease and
myocardial infarction. Although various gene polymorphsims have been studied in
patients with CAE, b-ﬁbrinogen gene polymorphisms have not been studied previ-
ously. We investigated relationship between b-ﬁbrinogen -455 G>A gene poly-
morphism and CAE.
Methods: Sixty ﬁve patients with isolated CAE (mean age 537 years) and 65 controls
with normal coronary angiograms (mean age 517 years) were included in the study.
The types of b-ﬁbrinogen -455G>A gene polymorphisms were analysed by polymerase
chain reaction and restriction fragment length polymorphism. For each polymorphic
position, one of three possible patterns may be obtained: Normal (GG) genotype,
heterozygous (GA), or homozygous (AA) mutant genotype. Demographic characteris-
tics and major risk factors for atherosclerosis were evaluated in the study groups.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. The frequency of the GA heterozygous genotype was signiﬁcantly higher in
CAE group than controls (39 (60%) vs 25 (38.5%), p¼0.014). Between the two groups
were compared according to the dominant genetic model (GA+AA vs. GG), The
number of patients carrying at least one A mutant allele (GA+AA) were signiﬁcantlyC54 JACC Vhigher in CAE than controls (44 (67.7%) vs 26 (40%), p¼0.002). With respect to allelic
distribution (G vs A, additive model), the frequency of the A mutant allele was
signiﬁcantly higher in CAE patients. (49 (37.6%) vs 27 (20.7%), p¼0.004).
Conclusions: In this study, we found that the frequency of b-ﬁbrinogen -455 G>A
polymorphism was higher in patients with CAE compared to control subject.
However, further large-sized studies are required for determining relationship between
b-ﬁbrinogen – 455 G>A gene polymorphisms and CAE.
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Background: Slow coronary ﬂow (SCF) is characterized by delay of opaciﬁcation of
coronary arteries in coronary angiography in the absence of any evident obstructive
lesion. Its pathophysiological mechanisms are uncertain. Several hypotheses have
been suggested for SCF, including a form of early phase of atherosclerosis, micro-
vascular dysfunction, inﬂammation, imbalance between vasoconstrictor and vaso-
dilatory factors, and platelet function disorder. Endothelial nitric oxide synthase
(eNOS) gene T-786 C polymorphism have been reported to be associated with many
vascular disease.
Objective: The aim of this study was to investigate the association between SCF and
eNOS gene T-786 C polymorphism.
Methods: Forty patients with SCF and otherwise normal coronary arteries (mean age
529 years), 35 patients with coronary artery disease (CAD) (mean age 559 years)
and 30 patients with normal coronary angiograms (mean age 518 years) were
included in the study. TIMI frame count 40 frames for the left anterior descending
artery was considered as SCF. T-786 C polymorphisms of the eNOS gene were
analysed by polymerase chain reaction. Demographic characteristics and major risk
factors for atherosclerosis were evaluated in the study groups. The severity of SCF and
CAD was assessed based on the number of involved vessel.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. The percentage of smoking was higher in the CAD group than in the SCF and
control groups. There was no statistical difference in genotype distribution among the
groups. The genotype distribution in SCF group was as follows: TT genotype frequency
was 25 (62,5%)k, TC genotype frequency was 12 (30%) and CC genotype frequency
was 3 (7,5%). The genotype distribution in CAD group was as follows: TT genotype
frequency was 16 (45,7%), TC genotype frequency was 16 (45,7%) and CC genotype
frequency was 3 (8,5%). The genotype distribution in control group was as follows: TT
genotype frequency was 17 (56,6%), TC genotype frequency was 10 (33,3%) and CC
genotype frequency was 3 (10%). In the dominant and recessive models of statistical
analysis, there was no statistically signiﬁcant difference among groups.
Conclusions: Our ﬁndings show that there is no signiﬁcant association between T-786
C polymorphism of eNOS gene and SCF in the present study.
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Background: Slow coronary ﬂow (SCF) is slow progression of contrast agent in the
coronary arteries in the absence of stenosis in epicardial coronary vessels. Its patho-
physiological mechanisms are uncertain. Several hypotheses have been suggested for
SCF, including a form of early phase of atherosclerosis, microvascular dysfunction,
inﬂammation, imbalance between vasoconstrictor and vasodilatory factors, and
platelet function disorder. Endothelial nitric oxide synthase (eNOS) has important role
in modulating smooth muscle tonus and vessel diameter. eNOS gene Glu298Asp
polymorphism has been associated with altered function of this gene and its products.
Experimental and clinical data suggesting that; in the absence of eNOS, endothelial
functions and luminal remodeling is impaired, the vessel wall thickness is increased,
atherosclerosis accelerated and got complicated.
Objective: The aim of this study was to investigate the association between SCF and
eNOS gene Glu298Asp polymorphism.
Methods: Forty patients with SCF and otherwise normal coronary arteries (mean age
529 years), 35 patients with coronary artery disease (CAD) (mean age 559 years)
and 30 patients with normal coronary angiograms (mean age 518 years) were
included in the study. TIMI frame count 40 frames for the left anterior descending
artery was considered as SCF. Glu298Asp polymorphisms of the eNOS gene wereol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
